2021 Q4 Form 10-K Financial Statement

#000155837022003664 Filed on March 15, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021
Revenue $37.73M $34.58M $137.4M
YoY Change 39.57% 35.76% 44.08%
Cost Of Revenue $25.59M $23.08M $89.98M
YoY Change 43.22% 38.62% 38.25%
Gross Profit $12.14M $11.50M $47.41M
YoY Change 32.49% 30.35% 56.61%
Gross Profit Margin 32.17% 33.26% 34.51%
Selling, General & Admin $6.348M $6.476M $24.19M
YoY Change 24.96% 40.08% 25.98%
% of Gross Profit 52.29% 56.31% 51.02%
Research & Development $2.757M $2.629M $10.33M
YoY Change 27.64% 29.96% 44.75%
% of Gross Profit 22.71% 22.86% 21.78%
Depreciation & Amortization $1.993M $1.824M $7.100M
YoY Change 45.47% 84.24% 65.12%
% of Gross Profit 16.42% 15.86% 14.97%
Operating Expenses $9.105M $9.105M $34.52M
YoY Change 25.59% 37.0% 31.07%
Operating Profit $3.034M $2.396M $12.90M
YoY Change 58.68% 10.06% 227.34%
Interest Expense $278.0K $972.0K $3.762M
YoY Change 826.67% -707.5% -852.4%
% of Operating Profit 9.16% 40.57% 29.17%
Other Income/Expense, Net -$90.00K $948.0K $509.0K
YoY Change -116.36% -2888.24% -84.09%
Pretax Income $3.222M $4.361M $17.60M
YoY Change 29.4% 105.9% 147.89%
Income Tax -$411.0K -$135.0K $1.093M
% Of Pretax Income -12.76% -3.1% 6.21%
Net Earnings $2.965M $3.800M $14.58M
YoY Change 43.65% 283.45% 350.12%
Net Earnings / Revenue 7.86% 10.99% 10.61%
Basic Earnings Per Share $0.07 $0.09 $0.35
Diluted Earnings Per Share $0.07 $0.09 $0.34
COMMON SHARES
Basic Shares Outstanding 42.77M 41.46M 41.37M
Diluted Shares Outstanding 42.68M 42.72M

Balance Sheet

Concept 2021 Q4 2021 Q3 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.18M $49.29M $42.18M
YoY Change -42.06% 83.23% -42.06%
Cash & Equivalents $36.76M $43.61M $36.76M
Short-Term Investments $5.419M $5.681M $5.419M
Other Short-Term Assets $17.25M $13.06M $17.25M
YoY Change 10.59% 23.23% 10.59%
Inventory $65.91M $60.68M $65.91M
Prepaid Expenses
Receivables $34.84M $36.58M $34.84M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $160.2M $159.6M $160.2M
YoY Change -2.63% 47.05% -2.62%
LONG-TERM ASSETS
Property, Plant & Equipment $142.4M $131.6M $144.7M
YoY Change 22.96% 21.54% 22.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.17M $9.340M $19.74M
YoY Change 59.44% 60.32% 63.16%
Other Assets $17.94M $15.35M $5.668M
YoY Change 77.46% 48.88% 53.19%
Total Long-Term Assets $172.3M $156.0M $172.3M
YoY Change 28.22% 25.65% 28.17%
TOTAL ASSETS
Total Short-Term Assets $160.2M $159.6M $160.2M
Total Long-Term Assets $172.3M $156.0M $172.3M
Total Assets $332.4M $315.7M $332.4M
YoY Change 11.24% 35.63% 11.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.65M $11.38M $19.62M
YoY Change 31.42% -7.23% 20.39%
Accrued Expenses $17.06M $12.67M $9.305M
YoY Change 6.64% 16.86% 16.31%
Deferred Revenue $946.0K $345.0K
YoY Change 152.94% -30.16%
Short-Term Debt $14.12M $13.29M $14.12M
YoY Change 35.73% 290.74% 35.73%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $47.82M $37.34M $47.82M
YoY Change 22.39% 40.94% 22.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $929.0K $0.00
YoY Change
Other Long-Term Liabilities $2.453M $1.628M $4.388M
YoY Change 30.41% 118.82% 2.05%
Total Long-Term Liabilities $2.453M $1.628M $4.388M
YoY Change 30.41% 118.82% 2.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.82M $37.34M $47.82M
Total Long-Term Liabilities $2.453M $1.628M $4.388M
Total Liabilities $52.21M $41.93M $120.9M
YoY Change 20.49% 35.94% 13.85%
SHAREHOLDERS EQUITY
Retained Earnings -$29.97M -$32.94M
YoY Change -32.72% -29.34%
Common Stock $231.7M $230.6M
YoY Change 0.54% -4.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $211.5M $205.7M $211.5M
YoY Change
Total Liabilities & Shareholders Equity $332.4M $315.7M $332.4M
YoY Change 11.24% 35.63% 11.22%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021
OPERATING ACTIVITIES
Net Income $2.965M $3.800M $14.58M
YoY Change 43.65% 283.45% 350.12%
Depreciation, Depletion And Amortization $1.993M $1.824M $7.100M
YoY Change 45.47% 84.24% 65.12%
Cash From Operating Activities $7.432M -$168.0K -$3.305M
YoY Change -1751.56% -103.87% -156.35%
INVESTING ACTIVITIES
Capital Expenditures -$10.55M -$6.062M $29.65M
YoY Change 36.3% 7.29% 49.31%
Acquisitions
YoY Change
Other Investing Activities -$2.714M -$6.691M -$9.165M
YoY Change -292.48% 364.65% -367.2%
Cash From Investing Activities -$13.26M -$12.75M -$38.81M
YoY Change 109.87% 79.62% 136.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.354M 3.857M 5.725M
YoY Change -102.52% -314.28% -89.13%
NET CHANGE
Cash From Operating Activities 7.432M -168.0K -3.305M
Cash From Investing Activities -13.26M -12.75M -38.81M
Cash From Financing Activities -1.354M 3.857M 5.725M
Net Change In Cash -7.186M -9.064M -35.84M
YoY Change -115.33% 98.77% -178.41%
FREE CASH FLOW
Cash From Operating Activities $7.432M -$168.0K -$3.305M
Capital Expenditures -$10.55M -$6.062M $29.65M
Free Cash Flow $17.98M $5.894M -$32.95M
YoY Change 146.67% -41.0% 135.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021 dei Entity Registrant Name
EntityRegistrantName
AXT INC
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
883000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
883000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41967000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42886000
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001051627
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
118508000
CY2021Q4 us-gaap Residual Value Of Leased Asset
ResidualValueOfLeasedAsset
0
CY2021Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021 dei Auditor Location
AuditorLocation
San Jose, California
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36763000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72602000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
5419000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
240000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
217000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34839000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24558000
CY2021Q4 us-gaap Inventory Net
InventoryNet
65912000
CY2020Q4 us-gaap Inventory Net
InventoryNet
51515000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17252000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15603000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
160185000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
883000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
883000
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
000-24085
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3031310
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
4281 Technology Drive
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Fremont
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94538
CY2021 dei City Area Code
CityAreaCode
510
CY2021 dei Local Phone Number
LocalPhoneNumber
438-4700
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2021 dei Trading Symbol
TradingSymbol
AXTI
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
351452364
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42960477
CY2021 dei Auditor Firm
AuditorFirmId
207
CY2021 dei Auditor Name
AuditorName
BPM LLP
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
130000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
164518000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
9576000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1934000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
5726000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
142415000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
115825000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2324000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2683000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17941000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10110000
CY2021Q4 us-gaap Assets
Assets
332441000
CY2020Q4 us-gaap Assets
Assets
298862000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16649000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12669000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17057000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15995000
CY2021Q4 axti Short Term Loan Noncontrolling Interest
ShortTermLoanNoncontrollingInterest
1887000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
12229000
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
10411000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
47822000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
39075000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1935000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2374000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2453000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1881000
CY2021Q4 us-gaap Liabilities
Liabilities
52210000
CY2020Q4 us-gaap Liabilities
Liabilities
43330000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
50385000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
47563000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
883000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
883000
CY2021Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
7522000
CY2020Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
7346000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
3532000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
3532000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42886000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41967000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
43000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
42000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
231622000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
230381000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29970000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44545000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
111000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1876000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
509000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3200000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6302000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3209000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
211529000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
192619000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
18317000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
15350000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
229846000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
207969000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
332441000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
298862000
CY2021 us-gaap Revenues
Revenues
137393000
CY2020 us-gaap Revenues
Revenues
95361000
CY2019 us-gaap Revenues
Revenues
83256000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
89979000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
65086000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
58431000
CY2021 us-gaap Gross Profit
GrossProfit
47414000
CY2020 us-gaap Gross Profit
GrossProfit
30275000
CY2019 us-gaap Gross Profit
GrossProfit
24825000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24189000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19200000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19305000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10328000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7135000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5834000
CY2021 us-gaap Operating Expenses
OperatingExpenses
34517000
CY2020 us-gaap Operating Expenses
OperatingExpenses
26335000
CY2019 us-gaap Operating Expenses
OperatingExpenses
25139000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
12897000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
3940000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-314000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
-213000
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
-179000
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
217000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4409000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
947000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17602000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
562000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7072000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1026000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1093000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2031000
CY2021 us-gaap Profit Loss
ProfitLoss
16509000
CY2020 us-gaap Profit Loss
ProfitLoss
5041000
CY2019 us-gaap Profit Loss
ProfitLoss
-1588000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1803000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1012000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
14575000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
3238000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-2600000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41367000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40152000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39487000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42720000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41025000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39487000
CY2021 us-gaap Profit Loss
ProfitLoss
16509000
CY2020 us-gaap Profit Loss
ProfitLoss
5041000
CY2019 us-gaap Profit Loss
ProfitLoss
-1588000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3719000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
8443000
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1847000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-68000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
81000
CY2019 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
617000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3651000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8449000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2383000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
20160000
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13490000
CY2019 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3971000
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2492000
CY2020 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2181000
CY2019 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1519000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17668000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11309000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5490000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
194532000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
268000
CY2019 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
617000
CY2019 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
413000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2346000
CY2019 us-gaap Profit Loss
ProfitLoss
-1588000
CY2019 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-1766000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
192762000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2536000
CY2020 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
396000
CY2020 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
1600000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2623000
CY2020 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2238000
CY2020 us-gaap Profit Loss
ProfitLoss
5041000
CY2020 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
8449000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
207969000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1670000
CY2021 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1151000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4519000
CY2021 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
3730000
CY2021 axti Transfer Of Subsidiary With Redeemable Noncontrolling Interest
TransferOfSubsidiaryWithRedeemableNoncontrollingInterest
1241000
CY2021 axti Stock Based Compensation Attributable To Noncontrolling Interest
StockBasedCompensationAttributableToNoncontrollingInterest
22000
CY2021 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
538000
CY2021 axti Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Other Nonredeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsOtherNonredeemable
15620000
CY2021 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
3372000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
229846000
CY2021 us-gaap Profit Loss
ProfitLoss
16509000
CY2020 us-gaap Profit Loss
ProfitLoss
5041000
CY2019 us-gaap Profit Loss
ProfitLoss
-1588000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7078000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4333000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5531000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-68000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-34000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-37000
CY2019 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
1068000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4519000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2623000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2346000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
183000
CY2019 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
175000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
8000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-50000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-72000
CY2021 axti Equity Method Investment Returns Or Dividends
EquityMethodInvestmentReturnsOrDividends
774000
CY2019 axti Equity Method Investment Returns Or Dividends
EquityMethodInvestmentReturnsOrDividends
362000
CY2021 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
4409000
CY2020 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
111000
CY2019 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-983000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2340000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9661000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5333000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-441000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12401000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
916000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8862000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
798000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6719000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2936000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6283000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
104000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1188000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3563000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2305000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3137000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3445000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2601000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4010000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1151000
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1878000
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
118000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3305000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5865000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12658000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29645000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19855000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21792000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
9645000
CY2020 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
5968000
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
8725000
CY2021 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
480000
CY2020 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
9401000
CY2019 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
22189000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38810000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16422000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8328000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1670000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2536000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
268000
CY2019 axti Proceeds From Sale Of Subsidiary Shares To Noncontrolling Interests Net
ProceedsFromSaleOfSubsidiarySharesToNoncontrollingInterestsNet
366000
CY2019 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
262000
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
20543000
CY2020 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
10401000
CY2019 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5814000
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1834000
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
19066000
CY2020 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
5996000
CY2021 axti Proceeds From Sale Of Subsidiary Shares To Noncontrolling Interests Net
ProceedsFromSaleOfSubsidiarySharesToNoncontrollingInterestsNet
538000
CY2020 axti Proceeds From Sale Of Subsidiary Shares To Noncontrolling Interests Net
ProceedsFromSaleOfSubsidiarySharesToNoncontrollingInterestsNet
396000
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1283000
CY2021 axti Proceeds From Issuance Of Common Stock To Redeemable Non Controlling Interests
ProceedsFromIssuanceOfCommonStockToRedeemableNonControllingInterests
-1077000
CY2020 axti Proceeds From Issuance Of Common Stock To Redeemable Non Controlling Interests
ProceedsFromIssuanceOfCommonStockToRedeemableNonControllingInterests
47563000
CY2020 axti Payments Of Dividends By Joint Ventures
PaymentsOfDividendsByJointVentures
2238000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5725000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52662000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6186000
CY2020 axti Minority Investment Entities Not Consolidated Accounted For By Equity Method
MinorityInvestmentEntitiesNotConsolidatedAccountedForByEquityMethod
5
CY2021 axti Minority Investment Entities Not Consolidated Accounted For By Equity Method
MinorityInvestmentEntitiesNotConsolidatedAccountedForByEquityMethod
5
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3605000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-150000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35839000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
45710000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10366000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72602000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26892000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16526000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36763000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72602000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26892000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
3177000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
1959000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
749000
CY2020 axti Considerations Paid Repurchase Subsidiary Shares
ConsiderationsPaidRepurchaseSubsidiaryShares
1439000
CY2019 axti Considerations Paid Repurchase Subsidiary Shares
ConsiderationsPaidRepurchaseSubsidiaryShares
151000
CY2020 axti Reduction Of Noncontrolling Interests
ReductionOfNoncontrollingInterests
-1398000
CY2019 axti Reduction Of Noncontrolling Interests
ReductionOfNoncontrollingInterests
-74000
CY2021 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
2974000
CY2020 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
1457000
CY2019 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
1447000
CY2021 axti Number Of Product Lines
NumberOfProductLines
2
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates, judgments and assumptions. We believe that the estimates, judgments, and assumptions upon which management relies are reasonable based on information available </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between these estimates and actual results, our consolidated financial statements would be affected.</p>
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-434000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-411000
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
321000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
946000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
374000
CY2021Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
266000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021 us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2021 us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 11pt 0pt;"><span style="font-style:italic;font-weight:bold;">Risks and Concentration of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 11pt 0pt;">Our business is very dependent on the semiconductor, lasers and optical industries which can be highly cyclical and experience downturns as a result of economic changes, overcapacity, and technological advancements. Significant technological changes in the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect our operating results. In addition, a significant portion of our revenues and net income is derived from international sales. Fluctuations of the United States dollar against foreign currencies and changes in local regulatory or economic conditions, particularly in an emerging market such as China, could adversely affect operating results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 11pt 0pt;">We depend on a limited number of suppliers for certain raw materials, components and equipment used in manufacturing our products, including quartz tubing and polishing solutions. We generally purchase these materials through standard purchase orders and not pursuant to long-term supply contracts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents, investments, and accounts receivable. We invest primarily in money market accounts, certificates of deposit and corporate bonds. The composition and maturities are regularly monitored by management. Such deposits are in excess of the amount of the insurance provided by the federal government on such deposits. We are exposed to credit risks in the event of default by the issuers to the extent of the amount recorded on the consolidated balance sheets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We perform ongoing credit evaluations of our customers’ financial condition, and limit the amount of credit extended when deemed necessary, but generally do not require collateral. The credit risk in our accounts receivable is mitigated by our credit evaluation process and the geographical dispersion of sales transactions. No customer accounted for more than 10% of our accounts receivable as of December 31, 2021 and two customers accounted for 11% and 10% of our accounts receivable as of December <span style="white-space:pre-wrap;">31, 2020. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 11pt 0pt;"><span style="background:#ffffff;">No customers represented more than 10% of our revenue for the year ended December 31, 2021. </span>One customer represented 11% of our revenue for the year ended December 31, 2020. One customer represented 15% of our revenue for the year ended December 31, 2019. Our top five customers, although not the same five customers for each period, represented 26% of our revenue for the year 2021, 32% of our revenue for 2020 and 40% of our revenue for 2019. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 11pt 0pt;">For the years ended December 31, 2021 and 2020, one third-party customer for the raw materials products from our consolidated subsidiaries accounted for over 10% of the revenue from raw materials sales. For the year ended December 31, 2019, each of three third-party customers for the raw materials products from our consolidated subsidiaries accounted for over 10% of the revenue from raw materials sales. Our subsidiaries and raw material joint ventures are a key strategic benefit for us as they further diversify our sources of revenue.</p>
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34800000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24600000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
743000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
609000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6302000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3209000
CY2021Q4 us-gaap Cash
Cash
36763000
CY2021Q4 us-gaap Cash
Cash
36763000
CY2020Q4 us-gaap Cash
Cash
72602000
CY2020Q4 us-gaap Cash
Cash
72602000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36763000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36763000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72602000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72602000
CY2021Q4 axti Cash And Cash Equivalents And Debt Securities Available For Sale Amortized Cost
CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleAmortizedCost
51823000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
65000
CY2021 axti Cash And Cash Equivalents And Debt Securities Available For Sale
CashAndCashEquivalentsAndDebtSecuritiesAvailableForSale
51758000
CY2020Q4 axti Cash And Cash Equivalents And Debt Securities Available For Sale Amortized Cost
CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleAmortizedCost
78565000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000
CY2020 axti Cash And Cash Equivalents And Debt Securities Available For Sale
CashAndCashEquivalentsAndDebtSecuritiesAvailableForSale
78568000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
5424000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
5419000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
240000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
240000
CY2019Q4 axti Number Of Consolidated Joint Ventures
NumberOfConsolidatedJointVentures
1
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
9636000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
9576000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
5723000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5726000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
15060000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
14995000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5963000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5966000
CY2021 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
65000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
12151000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
61000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
2013000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
4000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
14164000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
65000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
2048000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
2048000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2000
CY2021 axti Minority Investment Entities Not Consolidated Accounted For By Equity Method
MinorityInvestmentEntitiesNotConsolidatedAccountedForByEquityMethod
5
CY2021Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 axti Number Of Consolidated Joint Ventures
NumberOfConsolidatedJointVentures
1
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4300000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5500000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29658000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
24738000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
32605000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
24215000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3649000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2562000
CY2021Q4 us-gaap Inventory Net
InventoryNet
65912000
CY2020Q4 us-gaap Inventory Net
InventoryNet
51515000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
19600000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
17700000
CY2021Q4 axti Excess And Obsolete Inventory
ExcessAndObsoleteInventory
66000
CY2020Q4 axti Excess And Obsolete Inventory
ExcessAndObsoleteInventory
162000
CY2019 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
366000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
142415000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
115825000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7100000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10166000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
6376000
CY2019 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
366000
CY2019 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
175000
CY2019Q1 us-gaap Retained Interest Fair Value Disclosure
RetainedInterestFairValueDisclosure
2040000
CY2021 axti Schedule Of Gain Loss On Deconsolidation Of Subsidiary
ScheduleOfGainLossOnDeconsolidationOfSubsidiary
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:83.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:83.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:83.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value of the consideration received</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 366</p></td></tr><tr><td style="vertical-align:bottom;width:83.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value of the retained investment in Beijing JiYa Semiconductor Material Co., Ltd.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,040</p></td></tr><tr><td style="vertical-align:bottom;width:83.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Carrying value of noncontrolling interests, net of accumulated other comprehensive income attributable to subsidiary</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 617</p></td></tr><tr><td style="vertical-align:bottom;width:83.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Derecognition of Beijing JiYa Semiconductor Material Co., Ltd.'s net asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,848)</p></td></tr><tr><td style="vertical-align:bottom;width:83.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gain recognized on deconsolidation of Beijing JiYa Semiconductor Material Co., Ltd.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 175</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:83.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:83.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:83.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:83.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:83.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value of the retained investment in Beijing JiYa Semiconductor Material Co., Ltd.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,040</p></td></tr><tr><td style="vertical-align:bottom;width:83.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Carrying value of retained noncontrolling investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,559)</p></td></tr><tr><td style="vertical-align:bottom;width:83.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gain on retained noncontrolling investment due to remeasurement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 481</p></td></tr></table>
CY2019 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
366000
CY2019Q4 us-gaap Retained Interest Fair Value Disclosure
RetainedInterestFairValueDisclosure
2040000
CY2019Q4 axti Non Controlling Interest Net Of Accumulated Other Comprehensive Income Attributable To Subsidiary Carrying Value
NonControllingInterestNetOfAccumulatedOtherComprehensiveIncomeAttributableToSubsidiaryCarryingValue
617000
CY2019Q4 axti Derecognition Of Net Assets
DerecognitionOfNetAssets
-2848000
CY2019 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
175000
CY2019Q4 us-gaap Retained Interest Fair Value Disclosure
RetainedInterestFairValueDisclosure
2040000
CY2019Q4 axti Retained Noncontrolling Investment Carrying Value
RetainedNoncontrollingInvestmentCarryingValue
-1559000
CY2019 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
481000
CY2021 axti Number Of Fully Impaired Entities
NumberOfFullyImpairedEntities
1
CY2021 axti Number Of Fully Impaired Entities
NumberOfFullyImpairedEntities
1
CY2021 axti Number Of Fully Impaired Entities
NumberOfFullyImpairedEntities
1
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10166000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
6376000
CY2021Q4 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
959000
CY2020Q4 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
471000
CY2021Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
2107000
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1682000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2340000
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2369000
CY2020Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1581000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17941000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10110000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5115000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4417000
CY2021Q4 axti Current Payable In Connection With Constructions
CurrentPayableInConnectionWithConstructions
2974000
CY2020Q4 axti Current Payable In Connection With Constructions
CurrentPayableInConnectionWithConstructions
1457000
CY2021Q4 axti Preferred Stock Dividends Payable
PreferredStockDividendsPayable
2901000
CY2020Q4 axti Preferred Stock Dividends Payable
PreferredStockDividendsPayable
2901000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
946000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
374000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
880000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
675000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
743000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
609000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
539000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
760000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
488000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
445000
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
392000
CY2020Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
295000
CY2021Q4 axti Other Personnel Related Costs Current
OtherPersonnelRelatedCostsCurrent
279000
CY2020Q4 axti Other Personnel Related Costs Current
OtherPersonnelRelatedCostsCurrent
101000
CY2021Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
48000
CY2020Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
81000
CY2020Q4 axti Current Payable Connection Purchase Subsidiary Shares
CurrentPayableConnectionPurchaseSubsidiaryShares
1439000
CY2020Q4 axti Current Payable Connection Decontamination Of Nanjing Jinmei Factory
CurrentPayableConnectionDecontaminationOfNanjingJinmeiFactory
750000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1752000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1691000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17057000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15995000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
883000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
883000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
3532000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
3532000
CY2020 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.050
CY2021 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.050
CY2021Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2020Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1378000
CY2021Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
4.83
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1100000
CY2021Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
5.14
CY2019 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2346000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41367000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
14575000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
3238000
CY2020 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
396000
CY2021 axti Increase Decrease In Equity Purchase Subsidiary Shares
IncreaseDecreaseInEquityPurchaseSubsidiaryShares
-1039000
CY2020 axti Increase Decrease In Equity Purchase Subsidiary Shares
IncreaseDecreaseInEquityPurchaseSubsidiaryShares
-1398000
CY2021 axti Adjustments To Non Controlling Interests Formation Of New Subsidiary
AdjustmentsToNonControllingInterestsFormationOfNewSubsidiary
1413000
CY2021 axti Adjustments To Non Controlling Interests In Connection With Reorganization And Alignment Of Assets
AdjustmentsToNonControllingInterestsInConnectionWithReorganizationAndAlignmentOfAssets
1229000
CY2020 axti Adjustments To Non Controlling Interests In Connection With Reorganization And Alignment Of Assets
AdjustmentsToNonControllingInterestsInConnectionWithReorganizationAndAlignmentOfAssets
-10732000
CY2021 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
1603000
CY2020 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
-11734000
CY2021 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
16178000
CY2020 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-8496000
CY2014Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000.0
CY2015 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
908000
CY2015 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
2.52
CY2015 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2300000
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2021Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2700000
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40152000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39487000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42720000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41025000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39487000
CY2021 axti Effect Of Stock Based Compensation On Basic Earnings Per Share
EffectOfStockBasedCompensationOnBasicEarningsPerShare
0.11
CY2020 axti Effect Of Stock Based Compensation On Basic Earnings Per Share
EffectOfStockBasedCompensationOnBasicEarningsPerShare
0.07
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5911000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4500000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2600000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2300000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4519000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2623000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2346000
CY2021 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4519000
CY2020 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2623000
CY2019 axti Effect Of Stock Based Compensation On Basic Earnings Per Share
EffectOfStockBasedCompensationOnBasicEarningsPerShare
-0.06
CY2021 axti Effect Of Stock Based Compensation On Diluted Earnings Per Share
EffectOfStockBasedCompensationOnDilutedEarningsPerShare
0.11
CY2020 axti Effect Of Stock Based Compensation On Diluted Earnings Per Share
EffectOfStockBasedCompensationOnDilutedEarningsPerShare
0.06
CY2019 axti Effect Of Stock Based Compensation On Diluted Earnings Per Share
EffectOfStockBasedCompensationOnDilutedEarningsPerShare
-0.06
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.495
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0167
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 axti Period After Which All Full Time Employees Are Eligible To Participate In Savings Plan
PeriodAfterWhichAllFullTimeEmployeesAreEligibleToParticipateInSavingsPlan
P90D
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
208000
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
188000
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
176000
CY2021 axti Period Of Warranty
PeriodOfWarranty
P12M
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
609000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
387000
CY2021 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
711000
CY2020 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
510000
CY2021 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-100000
CY2020 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
186000
CY2021 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
477000
CY2020 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
474000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
743000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
609000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17600000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7100000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1000000.0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000
CY2019 axti Effective Income Tax Rate Reconciliation Foreign Income Tax Incentive
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxIncentive
0.322
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000.0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
223000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
91000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
15000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
27000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
3119000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2016000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
535000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3433000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2031000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
562000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
188000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
2151000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2340000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1093000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2031000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
562000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.004
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.002
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.021
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.254
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.008
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1.730
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.032
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.019
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.218
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.086
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.021
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
1.377
CY2021 axti Effective Income Tax Rate Reconciliation Foreign Income Tax Incentive
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxIncentive
-0.032
CY2020 axti Effective Income Tax Rate Reconciliation Foreign Income Tax Incentive
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxIncentive
-0.038
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Transition Tax On Accumulated Foreign Earnings Percent
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent
10.4
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
149000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2340000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Transition Tax On Accumulated Foreign Earnings Percent
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent
7.8
CY2021 axti Effective Income Tax Rate Reconciliation Gain Loss From Sale Of Intellectual Property Percent
EffectiveIncomeTaxRateReconciliationGainLossFromSaleOfIntellectualPropertyPercent
0.169
CY2021 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-0.026
CY2020 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0.011
CY2019 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-0.478
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.005
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.014
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.010
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.062
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.287
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.548
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11275000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14328000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
6056000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
3756000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
358000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1685000
CY2021Q4 axti Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
125000
CY2020Q4 axti Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
178000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17814000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19947000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15371000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19798000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2443000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
149000
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
103000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-4400000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
100000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
200000
CY2021 axti Benefit From Preferential Tax Rate Percentage
BenefitFromPreferentialTaxRatePercentage
0.10
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
14600000
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
14600000
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
14600000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
14575000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
3238000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-2600000
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
177000
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
177000
CY2019 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
177000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14398000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3061000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2777000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41367000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40152000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39487000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42720000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41025000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39487000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
137393000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
95361000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83256000
CY2021Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
144739000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
755000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-434000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-411000
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
321000
CY2021 axti Income Loss From Government Subsidy
IncomeLossFromGovernmentSubsidy
1125000
CY2020 axti Income Loss From Government Subsidy
IncomeLossFromGovernmentSubsidy
3800000
CY2019 axti Income Loss From Government Subsidy
IncomeLossFromGovernmentSubsidy
808000
CY2021 axti Other Nonoperating Income Expense Others
OtherNonoperatingIncomeExpenseOthers
-182000
CY2020 axti Other Nonoperating Income Expense Others
OtherNonoperatingIncomeExpenseOthers
-189000
CY2019 axti Other Nonoperating Income Expense Others
OtherNonoperatingIncomeExpenseOthers
-182000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
509000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3200000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
947000
CY2021Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
19467
CY2020Q2 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
0
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
591000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
581000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
292000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
293000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
292000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2804000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
381000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2423000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
488000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1935000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y5M8D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0461
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0461
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
570000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
456000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
533000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
512000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
119000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
89000
CY2021 us-gaap Lease Cost
LeaseCost
652000
CY2020 us-gaap Lease Cost
LeaseCost
601000
CY2021Q1 us-gaap Revenues
Revenues
31350000
CY2021Q2 us-gaap Revenues
Revenues
33735000
CY2021Q3 us-gaap Revenues
Revenues
34576000
CY2021Q4 us-gaap Revenues
Revenues
37732000
CY2021Q1 us-gaap Gross Profit
GrossProfit
11536000
CY2021Q2 us-gaap Gross Profit
GrossProfit
12238000
CY2021Q3 us-gaap Gross Profit
GrossProfit
11501000
CY2021Q4 us-gaap Gross Profit
GrossProfit
12139000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3425000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4385000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3800000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
2965000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2020Q1 us-gaap Revenues
Revenues
20723000
CY2020Q2 us-gaap Revenues
Revenues
22134000
CY2020Q3 us-gaap Revenues
Revenues
25469000
CY2020Q4 us-gaap Revenues
Revenues
27035000
CY2020Q1 us-gaap Gross Profit
GrossProfit
5522000
CY2020Q2 us-gaap Gross Profit
GrossProfit
6768000
CY2020Q3 us-gaap Gross Profit
GrossProfit
8823000
CY2020Q4 us-gaap Gross Profit
GrossProfit
9162000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-178000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
361000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
991000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
2064000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
48102000
CY2020 axti Redeemable Non Controlling Interests Stock Issuance Costs
RedeemableNonControllingInterestsStockIssuanceCosts
-539000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
47563000
CY2021 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
1514000
CY2021 axti Increase In Redeemable Noncontrolling Interests Due To Transfer Of Subsidiary With Noncontrolling Interests
IncreaseInRedeemableNoncontrollingInterestsDueToTransferOfSubsidiaryWithNoncontrollingInterests
1241000
CY2021 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
132000
CY2021 axti Redeemable Non Controlling Interests Stock Issuance Costs
RedeemableNonControllingInterestsStockIssuanceCosts
-2591000
CY2021 axti Stock Based Compensation Attributable To Redeemable Noncontrolling Interest
StockBasedCompensationAttributableToRedeemableNoncontrollingInterest
40000
CY2021 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
889000
CY2021 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
279000
CY2021 axti Effect Of Foreign Currency Translation On Redeemable Noncontrolling Interests
EffectOfForeignCurrencyTranslationOnRedeemableNoncontrollingInterests
1318000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
50385000

Files In Submission

Name View Source Status
0001558370-22-003664-index-headers.html Edgar Link pending
0001558370-22-003664-index.html Edgar Link pending
0001558370-22-003664.txt Edgar Link pending
0001558370-22-003664-xbrl.zip Edgar Link pending
axti-20211231.xsd Edgar Link pending
axti-20211231x10k.htm Edgar Link pending
axti-20211231x10k001.jpg Edgar Link pending
axti-20211231x10k003.jpg Edgar Link pending
axti-20211231x10k_htm.xml Edgar Link completed
axti-20211231xex10d11.htm Edgar Link pending
axti-20211231xex10d11da.htm Edgar Link pending
axti-20211231xex10d12.htm Edgar Link pending
axti-20211231xex10d12da.htm Edgar Link pending
axti-20211231xex10d13.htm Edgar Link pending
axti-20211231xex10d13da.htm Edgar Link pending
axti-20211231xex10d14.htm Edgar Link pending
axti-20211231xex10d15.htm Edgar Link pending
axti-20211231xex10d16.htm Edgar Link pending
axti-20211231xex10d17.htm Edgar Link pending
axti-20211231xex10d18.htm Edgar Link pending
axti-20211231xex10d19.htm Edgar Link pending
axti-20211231xex10d20.htm Edgar Link pending
axti-20211231xex10d21.htm Edgar Link pending
axti-20211231xex10d22.htm Edgar Link pending
axti-20211231xex10d23.htm Edgar Link pending
axti-20211231xex10d24.htm Edgar Link pending
axti-20211231xex10d25.htm Edgar Link pending
axti-20211231xex12d1.htm Edgar Link pending
axti-20211231xex21d1.htm Edgar Link pending
axti-20211231xex23d1.htm Edgar Link pending
axti-20211231xex31d1.htm Edgar Link pending
axti-20211231xex31d2.htm Edgar Link pending
axti-20211231xex32d1.htm Edgar Link pending
axti-20211231xex32d2.htm Edgar Link pending
axti-20211231xex4d1.htm Edgar Link pending
axti-20211231_cal.xml Edgar Link unprocessable
axti-20211231_def.xml Edgar Link unprocessable
axti-20211231_lab.xml Edgar Link unprocessable
axti-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending